News Categories
Featured News
0102030405
Cold Chain Expansion: UPS Invests $48 Million as Temperature-Controlled Logistics Demand Surges
2026-06-24
On June 22, United Parcel Service (UPS) announced a $48 million investment to upgrade 27 temperature-controlled logistics facilities across the Americas, Europe, and Asia—a move that signals a seismic shift in global cold chain infrastructure and, by extension, the materials that support it.
The Cold Chain Imperative
The investment is driven by explosive growth in temperature-sensitive pharmaceutical logistics. According to Growth Market Reports, the global temperature-controlled biologics market is projected to reach $39.1 billion by 2033, growing at a compound annual growth rate (CAGR) of 8.3%. The urgency is underscored by a striking WHO statistic: up to 50% of vaccines worldwide are wasted each year, largely due to cold chain storage failures.
UPS is positioning itself to capture a significant share of this expanding market. The company's healthcare division posted over $3 billion in revenue for the first quarter of 2026, with all three business segments achieving year-over-year growth. Since 2021, UPS has steadily gained market share in global healthcare logistics.
GLP-1 Drugs: The Catalyst
A key demand driver is the unprecedented rise of GLP-1 receptor agonists—drugs like Wegovy and Ozempic that require strict cold-chain handling throughout the entire transportation process. A Kaiser Family Foundation survey found that 1 in 8 Americans is currently taking a GLP-1 medication, creating logistics demand at a scale the industry has rarely seen.
"Our global transit hubs further strengthen end-to-end cold chain capabilities, ensuring that critical therapeutics reach patients worldwide safely and reliably," said Kate Gutmann, President of UPS International, Healthcare & Supply Chain Solutions.
What This Means for Thermal Label Paper
While the headlines focus on pharmaceutical companies and logistics giants, the ripple effects extend deep into the specialty paper supply chain. Here's why:
1. More Cold Chain Touchpoints = More labels
Each temperature-sensitive shipment requires labeling at multiple stages—origin, transit, storage, and last-mile delivery. As UPS expands its 27 temperature-controlled hubs and competitors follow suit, the volume of cold chain shipments—and the labels they require—will scale proportionally.
2. Stringent Traceability Demands
UPS emphasized that the investment will enhance end-to-end cargo traceability. In practice, this means more shipping labels, more tracking tags, and more documentation per shipment. Thermal label paper—particularly three-proof (waterproof, oil-proof, and alcohol-resistant) varieties—is the industry standard for these applications.
3. Performance Under Extremes
Cold chain logistics subject labeling materials to repeated temperature cycling, condensation, and moisture exposure. Standard labels fail in these conditions. BPA/BPS-free thermal paper with proven cold-chain durability is becoming a non-negotiable requirement for pharmaceutical shippers.
4. Regulatory Compliance Tightens
As pharmaceutical logistics regulations tighten globally—particularly in the EU and US—documentation requirements for temperature-controlled shipments are becoming more rigorous. Multi-part carbonless paper for invoices, packing lists, and customs declarations remains essential for compliant cross-border trade.
Industry-Wide Momentum
UPS is not alone in its cold chain expansion. Across the logistics industry, major players are investing heavily in temperature-controlled infrastructure, driven by the convergence of pharmaceutical growth, biologics demand, and regulatory pressure. This infrastructure buildout represents a long-term structural demand shift for the industrial paper and packaging materials that underpin these operations.
HESHUO®: Engineered for the Cold Chain
As cold chain logistics scale globally, the demand for reliable, compliant thermal and carbonless paper products will only intensify. HESHUO® manufactures three-proof thermal label paper specifically designed for cold chain and logistics applications—delivering clear, durable printing performance in freezing temperatures, high humidity, and condensation-prone environments.
All HESHUO® products are BPA/BPS-free, FSC-certified, and manufactured to ISO standards—meeting the stringent requirements of pharmaceutical, food safety, and international logistics supply chains.
When the cold chain grows, so does the need for labels that perform. That's where HESHUO® delivers.
Data source: UPS official announcement, June 22, 2026. Growth Market Reports; World Health Organization; Kaiser Family Foundation (KFF).










